BiotechTube
Home/Kala Pharmaceuticals/Kimberly Brown
KB

Kimberly Brown

Vice President, Operations

Kala Pharmaceuticals

Therapeutic Areas

OphthalmologyRare Diseases

Kala Pharmaceuticals Pipeline

DrugIndicationPhase
KPI-012Persistent Corneal Epithelial Defect (PCED)Phase 2b
KPI-014Inherited Retinal DegenerationsPreclinical

Leadership Team at Kala Pharmaceuticals

MI
Mark Iwicki
Chairman, President and Chief Executive Officer
EL
Eric L. Trachtenberg
General Counsel and Secretary
MK
Meredith Kaya
Vice President, Clinical Development
View full Kala Pharmaceuticals profile